{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:29:18Z","timestamp":1768076958452,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ygyno.2022.03.017","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:45:53Z","timestamp":1648773953000},"page":"486-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies"],"prefix":"10.1016","volume":"165","author":[{"given":"Joshua P.","family":"Schiff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafaa","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel T.","family":"Dyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie K.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie T.","family":"Markovina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry W.","family":"Grigsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2022.03.017_bb0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brachy.2018.11.002","article-title":"Use of interstitial brachytherapy in pelvic recurrence of cervical carcinoma: clinical response, survival, and toxicity","volume":"18","author":"da Silva","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0010","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.brachy.2017.11.011","article-title":"Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: a single-institution study","volume":"17","author":"Umezawa","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brachy.2019.10.003","article-title":"Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer","volume":"19","author":"Tiwari","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brachy.2011.06.008","article-title":"American brachytherapy society consensus guidelines for interstitial brachytherapy for vaginal cancer","volume":"11","author":"Beriwal","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2020.10.021","article-title":"3D image-guided interstitial brachytherapy for primary vaginal cancer: a multi-institutional experience","volume":"160","author":"Goodman","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.brachy.2019.05.007","article-title":"MRI-based interstitial brachytherapy for vaginal tumors: a multi-institutional study on practice patterns, contouring, and consensus definitions of target volumes","volume":"18","author":"Leung","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.radonc.2016.05.019","article-title":"Outcomes with image-based interstitial brachytherapy for vaginal cancer","volume":"120","author":"Manuel","year":"2016","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5114\/jcb.2016.58081","article-title":"Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer","volume":"8","author":"Kellas-\u015al\u0119czka","year":"2016","journal-title":"J. Contemp. Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brachy.2016.10.003","article-title":"Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: a single institutional experience","volume":"16","author":"Mahantshetty","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9378(99)70441-2","article-title":"Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer","volume":"181","author":"Tewari","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0055","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.brachy.2017.01.005","article-title":"Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma","volume":"16","author":"Castelnau-Marchand","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5114\/jcb.2016.57461","article-title":"High-dose-rate interstitial brachytherapy for female peri-urethral cancer","volume":"8","author":"Sharma","year":"2016","journal-title":"J. Contemp. Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/(SICI)1098-2388(199705\/06)13:3<208::AID-SSU9>3.0.CO;2-B","article-title":"Brachytherapy for cancer of the female urethra","volume":"13","author":"Micaily","year":"1997","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.brachy.2020.04.010","article-title":"Outcomes of freehand interstitial brachytherapy in advanced gynecologic malignancies","volume":"19","author":"Bajwa","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.brachy.2013.09.009","article-title":"Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience","volume":"13","author":"Mahantshetty","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brachy.2014.02.001","article-title":"CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience","volume":"13","author":"D\u2019Souza","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brachy.2012.08.006","article-title":"A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy","volume":"12","author":"Viswanathan","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijrobp.2019.10.037","article-title":"MRI- and PET-guided interstitial brachytherapy for postsurgical vaginal recurrences of cervical cancer: results of phase II study","volume":"106","author":"Chopra","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ygyno.2022.03.017_bb0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brachy.2014.11.017","article-title":"Outpatient-based high-dose-rate interstitial brachytherapy for gynecologic malignancies","volume":"14","author":"Dyk","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy\u20143D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brachy.2006.09.002","article-title":"High-dose-rate interstitial brachytherapy for gynecologic malignancies","volume":"5","author":"Beriwal","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.brachy.2012.11.002","article-title":"Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance","volume":"12","author":"Lee","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ygyno.2005.06.001","article-title":"The role of interstitial brachytherapy using template in locally advanced gynecological malignancies","volume":"99","author":"Agrawal","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0973-1482.34692","article-title":"Retrospective analysis of role of interstitial brachytherapy using template (MUPIT) in locally advanced gynecological malignancies","volume":"3","author":"Nandwani","year":"2007","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0125","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1088\/0031-9155\/56\/13\/014","article-title":"Implant strategies for endocervical and interstitial ultrasound hyperthermia adjunct to HDR brachytherapy for the treatment of cervical cancer","volume":"56","author":"Wootton","year":"2011","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2013.04.011","article-title":"HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy \u2013 a phase III study","volume":"109","author":"Zolciak-Siwinska","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2020.09.022","article-title":"Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer","volume":"154","author":"Gort","year":"2021","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0140","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ijrobp.2020.11.037","article-title":"Dosimetric impact of intrafraction motion in online-adaptive intensity modulated proton therapy for cervical cancer","volume":"109","author":"Berger","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13014-022-01981-z","article-title":"MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience","volume":"17","author":"Hadi","year":"2022","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0150","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0155","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ygyno.2012.01.034","article-title":"Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer","volume":"125","author":"Katanyoo","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/gyno.2000.5935","article-title":"A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix","volume":"79","author":"Nakanishi","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2010.11.022","article-title":"A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA","volume":"120","author":"Lee","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00003495-199958030-00006","article-title":"General anaesthesia: practical recommendations and recent advances","volume":"58","author":"Dodds","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cps.2013.07.001","article-title":"Complications of general anesthesia","volume":"40","author":"Harris","year":"2013","journal-title":"Clin. Plast. Surg."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0180","doi-asserted-by":"crossref","first-page":"598","DOI":"10.5732\/cjc.011.10452","article-title":"Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer","volume":"31","author":"Wang","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.03.017_bb0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/gyno.1997.4722","article-title":"Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina","volume":"66","author":"Nag","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0190","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2021.32.e85","article-title":"Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea","volume":"32","author":"Kim","year":"2021","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.017_bb0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11912-016-0508-y","article-title":"Brachytherapy in gynecologic cancers: why is it underused?","volume":"18","author":"Han","year":"2016","journal-title":"Curr. Oncol. Rep."},{"issue":"21","key":"10.1016\/j.ygyno.2022.03.017_bb0200","first-page":"00483","article-title":"Increasing global access to brachytherapy: the ABS 300 in 10 initiative and ongoing international efforts","volume":"S1538-4721","author":"Petereit","year":"2021","journal-title":"Brachytherapy"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822001998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822001998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:02:31Z","timestamp":1758772951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822001998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0090825822001998"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.03.017","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}